Base de dados : HANSEN
Pesquisa : ANTIMICOTICOS [Descritor de assunto]
Referências encontradas : 6 [refinar]
Mostrando: 1 .. 6   no formato [Detalhado]

página 1 de 1

  1 / 6 HANSEN  
              next record last record
seleciona
para imprimir
Id:18466
Autor:Reichart, P. A; Samaranayake, L. P; Samaranayake, Y. H; Grote, M; Pow, E; Cheung, B
Título:High oral prevalence of Candida krusei in leprosy patients in northern Thailand
..-
Fonte:s.l; s.n; Dec.2002. 7 p. tab, graf.
Resumo:Although Candida albicans is the most common human yeast pathogen, other Candida species such as C. krusei are now recognized as emerging agents, especially in patients with human immunodeficiency virus (HIV) disease. C. krusei is inherently resistant to the widely used triazole antifungal fluconazole and poses therapeutic problems, especially in systemic candidiasis. In a surveillance study of leprosy patients (with arrested or burnt-out disease) in a leprosarium in northern Thailand, we found a rate of oral carriage of C. krusei (36 per cent) significantly (P smaller 0.05) higher than that for a healthy control group (10 per cent). Among the Candida-positive patients, 16 of 35 (46 per cent) carried C. krusei, while C. albicans was the second most common isolate (12 of 35 patients; 34 per cent). The corresponding figures for the control group were 2 of 13 (15 per cent) and 6 of 13 (46 per cent), respectively. Studies of the antifungal resistance of the C. krusei isolates from patients indicated that all except one of the isolates were resistant to fluconazole, two isolates were resistant to ketoconazole, and all isolates were sensitive to amphotericin B. Evaluation of their genetic profiles by randomly amplified polymorphic DNA analysis with three different primers and subsequent analysis of the gel profiles by computerized cluster-derived dendrograms revealed that the C. krusei isolates from patients belonged to 10 disparate clusters, despite the origin from a single locale. These nascent findings indicate an alarmingly high prevalence of a Candida species resistant to a widely used antifungal in a part of the world where HIV disease is endemic. (AU).
Descritores:ANTIMICOTICOS/farmacol
CANDIDA/clas
CANDIDA/ef drogas
CANDIDA/genet
CANDIDA/isol
CANDIDIASE BUCAL/compl
CANDIDIASE BUCAL/epidemiol
CANDIDIASE BUCAL/microbiol
PORTADOR/epidemiol
PORTADOR/microbiol
Resistência Fúngica a Múltiplas Drogas
HANSENIASE/compl
TESTES DE SENSIBILIDADE MICROBIANA
BOCA/microbiol
PREVALÊNCIA
TECNICA DE AMPLIFICACAO AO ACASO DE DNA POLIMORFICO
TAILÂNDIA/epidemiol
Limites:HUMANO
MASCULINO
FEMININO
MEIA-IDADE
IDOSO
IDOSO DE 80 ANOS OU MAIS
Localização:BR191.1; 09003/s


  2 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18187
Autor:Holt, R. J
Título:Progress in antimycotic chemotherapy 1945-1980
..-
Fonte:s.l; s.n; 1980. 4 p. .
Resumo:Before 1950 no reliable or safe therapy existed for systemic and invasive mycoses, and only traditional and empirical topical preparations were available for dermatomycoses. Two distinct eras of rapid progress in antifungal therapy followed: first, in the 1950's came the introduction of the polyenes, nystatin and pimaricin for cutaneous, vaginal and intestinal candidiasis, and amphotericin B for the treatment of severe systemic mycoses. The second phase saw the successful introduction and clinical use of 5-fluorocytosine and several imidazole derivatives some twenty years later, at a time when the vast increase in iatrogenic systemic mycoses caused by opportunistic fungi had created an urgent and pressing need for new agents in addition to those still effective.(AU).
Descritores:ANFOTERICINA B/uso terap
ANTIBIOTICOS ANTIMICÓTICOS/uso terap
BLASTOMICOSE/quimioter
CANDIDIASE/quimioter
FLUCITOSINA/uso terap
IMIDAZOIS/uso terap
MICOSES/quimioter
NATAMICINA/uso terap
NISTATINA/uso terap
POLIENOS/uso terap
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 00488/s


  3 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15806
Autor:Bittencourt, Achiléa I; Machado, Paulo R. I; Araujo, Maria G. S
Título:Subcutaneous phaeohyphomycosis caused by cyphellophora pluriseptata
..-
Fonte:s.l; s.n; 2002. 4 p. ilus.
Descritores:ANTIMICOTICOS
DERMATOMICOSE
DERMATOMICOSE
OTOPATIAS
OTOPATIAS
ITRACONAZOL
ORELHA EXTERNA/*
FUNGOS MITOSPORICOS/*IP
Limites:RELATO DE CASO
Localização:BR191.1; 08524/s


  4 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15498
Autor:Dinesha,; Roshan, M; Dinesh, Kavitha R; Shetty, R; Jayaprakash, C. S; Raghuveer, C. V
Título:Pseudallescheriasis - a rare fungal infection of brain and lungs
..-
Fonte:s.l; s.n; 2001. 2 p. ilus.
Descritores:HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
CORTICOSTEROIDES
ANTIMICOTICOS
EVOLUÇAO FATAL
HOSPEDEIRO IMUNOCOMPROMETIDO
PNEUMOPATIAS FUNGICAS
PNEUMOPATIAS FUNGICAS
PNEUMOPATIAS FUNGICAS
PSEUDALLESCHERIA
Localização:BR191.1; 08349/s


  5 / 6 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14150
Autor:Birdi, Tannaz J; D'Souza, Sushila; Antia, Noshir H
Título:Expression of mycobacterial antigens on murine dissociated Schwann cells infected with Mycobacterium leprae
..-
Fonte:s.l; s.n; 1997. 5 p. graf.
Descritores:ANTICORPOS ANTIBACTÉRIAS
ANTIMICOTICOS
ANTIGENOS DE BACTÉRIAS
ANTIGENOS DE BACTÉRIAS
ANTIMALARICOS
MEMBRANA CELULAR
CLOROQUINA
ELISA
INTERFERON RECOMBINANTE GAMA
CINÉTICA
HANSENIASE
HANSENIASE
CAMUNDONGOS
MONENSIN
MYCOBACTERIUM LEPRAE
CÉLULAS DE SCHWANN
Limites:ANIMAL
Localização:BR191.1; 07116/s


  6 / 6 HANSEN  
              first record previous record
seleciona
para imprimir
Id:5716
Autor:Mendes, Ernesto; Raphael, Açucena; Mota, Norma G. S; Mendes, Nelson F
Título:Cell-mediated immunity in leprosy and transfer of delayed hypersensivity reactions
..-
Fonte:s.l; s.n; 1974. 7 p. tab.
Descritores:HANSENIASE
ANTIBIOTICOS ANTIMICOTICOS
ANTIGENOS
HIPERSENSIBILIDADE TARDIA
IMUNIDADE CELULAR
IMUNIZAÇAO
IMUNIZAÇAO PASSIVA
ANTIGENO DE MITSUDA
LINFOCITOS
NITROBENZENOS
TESTES CUTANEOS
TRICOFITINA
TESTE TUBERCULINICO
Localização:BR191.1; 02681/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information